Evaluation of 5-Carbamoylmethyluridine as an Indicator of Tumor Burden in Lung Cancer Patients
- 1 April 1990
- journal article
- abstracts
- Published by Taylor & Francis in Nucleosides and Nucleotides
- Vol. 9 (3) , 441-442
- https://doi.org/10.1080/07328319008045165
Abstract
Elevation of 5-carbamoylmethyluridine in the urines of non-small lung carcinoma patients suggests that this nucleoside may be used as an indicator of tumor burden for these patients.Keywords
This publication has 0 references indexed in Scilit: